Status:

COMPLETED

Exercise Booster Sessions in People With Multiple Sclerosis

Lead Sponsor:

University of Aarhus

Collaborating Sponsors:

Oxford Brookes University

Conditions:

Multiple Sclerosis

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

This study wants to investigate whether exercise booster sessions applied in the follow-up period after an exercise intervention can increase the sustainability of exercise induced effects in persons ...

Detailed Description

MS is a chronic, autoimmune, and inflammatory disease of the central nervous system, exemplified through marked demyelination and axonal loss. As a result, symptoms such as fatigue, numbness, weakness...

Eligibility Criteria

Inclusion

  • A definite diagnosis of MS, according to the McDonald criteria
  • Walking \<650m on 6MWT.
  • Exercising ≤ two sessions per week of moderate-to-high intensity during the past six months.

Exclusion

  • Comprise comorbidities (cardiovascular-, respiratory-, orthopedic- or other neurological diseases.)

Key Trial Info

Start Date :

August 1 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

October 4 2024

Estimated Enrollment :

150 Patients enrolled

Trial Details

Trial ID

NCT04913012

Start Date

August 1 2021

End Date

October 4 2024

Last Update

December 27 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Aarhus University

Aarhus, Denmark, 8000